Product pages are maintained with structured, plain-language information designed to help you understand ingredients, serving information, common uses, and related educational topics
Policies and Procedures for Related Party Transactions Our Board has adopted a policy that our executive officers, directors, nominees for election as a director, beneficial owners of more than 5% of any class of our common stock, any members of the immediate family of any of the foregoing persons and any firms, corporations or other entities in which any of the foregoing persons is employed or is a partner or principal or in a similar position or in which such person has a 5% or greater beneficial ownership interest, which we refer to collectively as related parties, are not permitted to enter into a transaction with us without the prior consent of our Board acting through the audit committee or, in certain circumstances, the chairman of the audit committee
The FDA warning letter addressed marketing claims, not medication safety concerns
What This Means for No DAC No large clinical trial has been run specifically on the No DAC variant
